The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124012824 12401282 4 F 2014 20160622 20160525 20160706 EXP CN-APOTEX-2016AP008529 APOTEX 42.00 YR F Y 57.00000 KG 20160706 CN GB CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124012824 12401282 1 PS PAXIL PAROXETINE HYDROCHLORIDE 1 Unknown UNK Y 20031 TABLET
124012824 12401282 2 SS PAXIL PAROXETINE HYDROCHLORIDE 1 Unknown 30 MG, QD Y 20031 30 MG TABLET
124012824 12401282 3 SS PAXIL PAROXETINE HYDROCHLORIDE 1 Unknown UNK Y 15060120; 20031 TABLET
124012824 12401282 4 SS FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 Unknown UNK Y 0
124012824 12401282 5 SS ZOLOFT SERTRALINE HYDROCHLORIDE 1 Unknown UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124012824 12401282 1 Anxiety
124012824 12401282 2 Panic disorder
124012824 12401282 4 Anxiety
124012824 12401282 5 Anxiety

Outcome of event

Event ID CASEID OUTC COD
124012824 12401282 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124012824 12401282 Abdominal discomfort
124012824 12401282 Abdominal pain
124012824 12401282 Abnormal faeces
124012824 12401282 Anxiety
124012824 12401282 Blood pressure increased
124012824 12401282 Bruxism
124012824 12401282 Discomfort
124012824 12401282 Disease recurrence
124012824 12401282 Dry mouth
124012824 12401282 Fatigue
124012824 12401282 Haematochezia
124012824 12401282 Hyperhidrosis
124012824 12401282 Hypoaesthesia
124012824 12401282 Insomnia
124012824 12401282 Menstrual disorder
124012824 12401282 Menstruation irregular
124012824 12401282 Movement disorder
124012824 12401282 Nausea
124012824 12401282 Nightmare
124012824 12401282 Nocturia
124012824 12401282 Somnolence
124012824 12401282 Tinnitus
124012824 12401282 Vascular headache
124012824 12401282 Vision blurred
124012824 12401282 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124012824 12401282 1 2014 20160515 0
124012824 12401282 2 2014 0
124012824 12401282 4 2015 201511 0
124012824 12401282 5 2016 0